- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-ENO1
ENO1 Polyclonal Antibody for WB, IHC, IF/ICC, IP, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
WB, IHC, IF/ICC, IP, Indirect ELISA
Conjugaison
Non conjugué
N° de cat : 55237-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
55237-1-PBS cible ENO1 dans les applications de WB, IHC, IF/ICC, IP, Indirect ELISA et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | Peptide |
| Nom complet | enolase 1, (alpha) |
| Masse moléculaire calculée | 47 kDa |
| Poids moléculaire observé | 47 kDa |
| Numéro d’acquisition GenBank | NM_001428 |
| Symbole du gène | ENO1 |
| Identification du gène (NCBI) | 2023 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
ENO1, also named as NNE, ENO1L1, MBPB1, MPB1 and MBP1, belongs to the enolase family. ENO1 is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and mediates the activation of plasmin and extracellular matrix degradation. In tumor cells, ENO1 is up-regulated and supports the Warburg effect; it is expressed at the cell surface, where it promotes cancer invasion, and is subjected to a specific array of post-translational modifications, namely acetylation, methylation and phosphorylation. ENO1 overexpression and post-translational modifications could be of diagnostic and prognostic value in many cancer types. (PMID: 27814656). This antibody is specific to ENO1 and has no cross reaction with ENO2 and ENO3.







































